Six-year outcome of a prospective study evaluating tumor bed boost with intra-operative electron irradiation followed by whole-breast irradiation for early-stage breast cancer

William W. Wong, Barbara A Pockaj, Sujay A. Vora, Michele Y. Halyard, Richard J. Gray, Steven E. Schild

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

A prospective study was performed for patients with early-stage breast cancer in which a single fraction of intraoperative electron irradiation (IOERT) was given to the tumor bed, followed by conventional fractionated whole-breast irradiation (WBRT). Patients with T1/T2N0 breast cancer underwent lumpectomy and sentinel lymph node biopsy. A tumor bed boost of 10 Gy of IOERT using 6-12 MeV electrons was administered by a dedicated mobile linear accelerator in the operating room. After adequate wound healing, 48 Gy WBRT was given to the whole breast in 24 fractions. Fifty-two patients were enrolled between February 2003 and January 2005. At a median follow-up of 79 months, there were two local relapses. The 6-year actuarial overall survival and distant control rates were 89% and 96%, respectively. At last follow-up, cosmesis was graded as excellent or good in 45 (87%), fair in five (10%), and poor in two patients (4%), respectively. Difficulty in wound healing occurred in two patients who had additional surgery later. One patient developed significant fibrosis after aspiration of a symptomatic seroma. The result of this pilot study shows the feasibility of using IOERT as the tumor bed boost in lieu of 6-8 days of standard electron beam treatment with good local control and cosmetic results. However, late surgical intervention of the lumpectomy bed may result in more pronounced tissue fibrosis and wound healing difficulty.

Original languageEnglish (US)
Pages (from-to)125-130
Number of pages6
JournalBreast Journal
Volume20
Issue number2
DOIs
StatePublished - 2014

Fingerprint

Breast
Prospective Studies
Electrons
Breast Neoplasms
Wound Healing
Neoplasms
Segmental Mastectomy
Fibrosis
Seroma
Sentinel Lymph Node Biopsy
Particle Accelerators
Operating Rooms
Cosmetics
Recurrence
Survival
Therapeutics

Keywords

  • boost irradiation
  • breast cancer
  • breast-conserving therapy
  • intraoperative radiotherapy
  • IOERT

ASJC Scopus subject areas

  • Internal Medicine
  • Oncology
  • Surgery

Cite this

Six-year outcome of a prospective study evaluating tumor bed boost with intra-operative electron irradiation followed by whole-breast irradiation for early-stage breast cancer. / Wong, William W.; Pockaj, Barbara A; Vora, Sujay A.; Halyard, Michele Y.; Gray, Richard J.; Schild, Steven E.

In: Breast Journal, Vol. 20, No. 2, 2014, p. 125-130.

Research output: Contribution to journalArticle

Wong, William W. ; Pockaj, Barbara A ; Vora, Sujay A. ; Halyard, Michele Y. ; Gray, Richard J. ; Schild, Steven E. / Six-year outcome of a prospective study evaluating tumor bed boost with intra-operative electron irradiation followed by whole-breast irradiation for early-stage breast cancer. In: Breast Journal. 2014 ; Vol. 20, No. 2. pp. 125-130.
@article{ec7a109a2c69453ca51631b1fdd2bdde,
title = "Six-year outcome of a prospective study evaluating tumor bed boost with intra-operative electron irradiation followed by whole-breast irradiation for early-stage breast cancer",
abstract = "A prospective study was performed for patients with early-stage breast cancer in which a single fraction of intraoperative electron irradiation (IOERT) was given to the tumor bed, followed by conventional fractionated whole-breast irradiation (WBRT). Patients with T1/T2N0 breast cancer underwent lumpectomy and sentinel lymph node biopsy. A tumor bed boost of 10 Gy of IOERT using 6-12 MeV electrons was administered by a dedicated mobile linear accelerator in the operating room. After adequate wound healing, 48 Gy WBRT was given to the whole breast in 24 fractions. Fifty-two patients were enrolled between February 2003 and January 2005. At a median follow-up of 79 months, there were two local relapses. The 6-year actuarial overall survival and distant control rates were 89{\%} and 96{\%}, respectively. At last follow-up, cosmesis was graded as excellent or good in 45 (87{\%}), fair in five (10{\%}), and poor in two patients (4{\%}), respectively. Difficulty in wound healing occurred in two patients who had additional surgery later. One patient developed significant fibrosis after aspiration of a symptomatic seroma. The result of this pilot study shows the feasibility of using IOERT as the tumor bed boost in lieu of 6-8 days of standard electron beam treatment with good local control and cosmetic results. However, late surgical intervention of the lumpectomy bed may result in more pronounced tissue fibrosis and wound healing difficulty.",
keywords = "boost irradiation, breast cancer, breast-conserving therapy, intraoperative radiotherapy, IOERT",
author = "Wong, {William W.} and Pockaj, {Barbara A} and Vora, {Sujay A.} and Halyard, {Michele Y.} and Gray, {Richard J.} and Schild, {Steven E.}",
year = "2014",
doi = "10.1111/tbj.12235",
language = "English (US)",
volume = "20",
pages = "125--130",
journal = "Breast Journal",
issn = "1075-122X",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Six-year outcome of a prospective study evaluating tumor bed boost with intra-operative electron irradiation followed by whole-breast irradiation for early-stage breast cancer

AU - Wong, William W.

AU - Pockaj, Barbara A

AU - Vora, Sujay A.

AU - Halyard, Michele Y.

AU - Gray, Richard J.

AU - Schild, Steven E.

PY - 2014

Y1 - 2014

N2 - A prospective study was performed for patients with early-stage breast cancer in which a single fraction of intraoperative electron irradiation (IOERT) was given to the tumor bed, followed by conventional fractionated whole-breast irradiation (WBRT). Patients with T1/T2N0 breast cancer underwent lumpectomy and sentinel lymph node biopsy. A tumor bed boost of 10 Gy of IOERT using 6-12 MeV electrons was administered by a dedicated mobile linear accelerator in the operating room. After adequate wound healing, 48 Gy WBRT was given to the whole breast in 24 fractions. Fifty-two patients were enrolled between February 2003 and January 2005. At a median follow-up of 79 months, there were two local relapses. The 6-year actuarial overall survival and distant control rates were 89% and 96%, respectively. At last follow-up, cosmesis was graded as excellent or good in 45 (87%), fair in five (10%), and poor in two patients (4%), respectively. Difficulty in wound healing occurred in two patients who had additional surgery later. One patient developed significant fibrosis after aspiration of a symptomatic seroma. The result of this pilot study shows the feasibility of using IOERT as the tumor bed boost in lieu of 6-8 days of standard electron beam treatment with good local control and cosmetic results. However, late surgical intervention of the lumpectomy bed may result in more pronounced tissue fibrosis and wound healing difficulty.

AB - A prospective study was performed for patients with early-stage breast cancer in which a single fraction of intraoperative electron irradiation (IOERT) was given to the tumor bed, followed by conventional fractionated whole-breast irradiation (WBRT). Patients with T1/T2N0 breast cancer underwent lumpectomy and sentinel lymph node biopsy. A tumor bed boost of 10 Gy of IOERT using 6-12 MeV electrons was administered by a dedicated mobile linear accelerator in the operating room. After adequate wound healing, 48 Gy WBRT was given to the whole breast in 24 fractions. Fifty-two patients were enrolled between February 2003 and January 2005. At a median follow-up of 79 months, there were two local relapses. The 6-year actuarial overall survival and distant control rates were 89% and 96%, respectively. At last follow-up, cosmesis was graded as excellent or good in 45 (87%), fair in five (10%), and poor in two patients (4%), respectively. Difficulty in wound healing occurred in two patients who had additional surgery later. One patient developed significant fibrosis after aspiration of a symptomatic seroma. The result of this pilot study shows the feasibility of using IOERT as the tumor bed boost in lieu of 6-8 days of standard electron beam treatment with good local control and cosmetic results. However, late surgical intervention of the lumpectomy bed may result in more pronounced tissue fibrosis and wound healing difficulty.

KW - boost irradiation

KW - breast cancer

KW - breast-conserving therapy

KW - intraoperative radiotherapy

KW - IOERT

UR - http://www.scopus.com/inward/record.url?scp=84896281474&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896281474&partnerID=8YFLogxK

U2 - 10.1111/tbj.12235

DO - 10.1111/tbj.12235

M3 - Article

C2 - 24372873

AN - SCOPUS:84896281474

VL - 20

SP - 125

EP - 130

JO - Breast Journal

JF - Breast Journal

SN - 1075-122X

IS - 2

ER -